Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug3290 | Recombinant human alkaline phosphatase Wiki | 1.00 |
drug2916 | Placebo Wiki | 0.04 |
Name (Synonyms) | Correlation | |
---|---|---|
D018805 | Sepsis NIH | 0.35 |
D058186 | Acute Kidney Injury NIH | 0.19 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0100806 | Sepsis HPO | 0.35 |
HP:0001919 | Acute kidney injury HPO | 0.19 |
Navigate: Correlations HPO
There is one clinical trial.
ACEI-COVID-19 is a multicenter, randomized trial testing the hypothesis that stopping/replacing chronic treatment with ACE-inhibitors (ACEI) or angiotensin receptor blockers (ARB) improves outcomes in symptomatic SARS-CoV2-infected patients
Description: The minimal value of the SOFA Score will be 0 and the maximal value 24 points. All-cause death is classified as the maximum score (24 points). In case of a subclinical disease progress without need for hospitalization, the SOFA score will be 0.
Measure: Combination of maximum Sequential Organ Failure Assessment (SOFA) Score and death Time: 30 daysDescription: minimum score is 0, maximum score is 24; higher score indicates poor outcome
Measure: Maximum and median maximum Sequential Organ Failure Assessment (SOFA) Score Time: 30 daysDescription: high-flow, continuous positive airway pressure therapy
Measure: Rates of non-invasive ventilation Time: 30 daysDescription: with causal relationship to stopping of ACEI/ARB therapy
Measure: Hospitalisation due to cardiac decompensation Time: 30 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports